Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767897 · ClinicalTrials.gov registry record
The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 72
- Enrollment target
NCT00767897: Completed study, sponsored by Indiana University.
NCT00767897 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767897 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The proposed study is a pilot study and a first step towards developing an optimized HPV vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.
Interventions
- DRUG Human Papillomavirus Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-11 |
| Est. Completion | 2018-12 |
What the finished NCT00767897 record still lists
NCT00767897 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Human Papillomavirus Vaccine is the first listed.
NCT00767897 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00767897 about?
NCT00767897 is a clinical study titled "The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients". The proposed study is a pilot study and a first step towards developing an optimized HPV vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.
What is the current status of trial NCT00767897?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2011-11. Estimated completion is 2018-12.
What interventions are being tested in trial NCT00767897?
The interventions under investigation include: Human Papillomavirus Vaccine (DRUG).
Who is sponsoring clinical trial NCT00767897?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia